CGEM

Cullinan Oncology LLC is an innovative biopharmaceutical company based in Cambridge, Massachusetts, dedicated to advancing targeted oncology and immuno-oncology therapies to improve outcomes for cancer patients. With a robust pipeline of therapeutic candidates addressing significant unmet needs in oncology, Cullinan is at the forefront of transforming cancer treatment through cutting-edge science and strategic partnerships. The company's commitment to pioneering research positions it as a vital player in the dynamic landscape of oncology therapeutics, aiming to bring forth impactful solutions for various cancer types.